Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ-Bridged Crystal Structure
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/167688 |
Resumo: | This work was cofinanced by national funds from FCT-Fundação para a Ciência e a Tecnologia, I.P., in the scope of the project UIDP/04378/2020 (doi: 10.54499/UIDP/04378/2020) and UIDB/04378/2020 (doi: 10.54499/UIDB/04378/2020) of the Research Unit on Applied Molecular Biosciences-UCIBIO and the project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy-i4HB and doctoral grant 2021.08629.BD (S.C.), and project NANOHEAT (doi: 10.54499/2022.04315.PTDC) and the Research Excellence Initiative of the University of Silesia in Katowice (B.M.). K.C. acknowledges funding from the National Science Center of Poland grant MINIATURA no. 2022/06/X/ST4/00351. Publisher Copyright: © 2024 The Authors. Published by American Chemical Society. |
id |
RCAP_f329e2904662aa39a057a32793f138a5 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/167688 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ-Bridged Crystal StructureBiological Activities from 2D and 3D Tumor Spheroids to In Vivo ModelsMolecular MedicineDrug DiscoverySDG 3 - Good Health and Well-beingThis work was cofinanced by national funds from FCT-Fundação para a Ciência e a Tecnologia, I.P., in the scope of the project UIDP/04378/2020 (doi: 10.54499/UIDP/04378/2020) and UIDB/04378/2020 (doi: 10.54499/UIDB/04378/2020) of the Research Unit on Applied Molecular Biosciences-UCIBIO and the project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy-i4HB and doctoral grant 2021.08629.BD (S.C.), and project NANOHEAT (doi: 10.54499/2022.04315.PTDC) and the Research Excellence Initiative of the University of Silesia in Katowice (B.M.). K.C. acknowledges funding from the National Science Center of Poland grant MINIATURA no. 2022/06/X/ST4/00351. Publisher Copyright: © 2024 The Authors. Published by American Chemical Society.Eight 2,2′:6′,2″-terpyridines, substituted at the 4′-position with aromatic groups featuring variations in π-conjugation, ring size, heteroatoms, and methoxy groups, were employed to enhance the antiproliferative potential of [Cu2Cl2(R-terpy)2](PF6)2. Assessing the cytotoxicity in A2780 (ovarian carcinoma), HCT116 (colorectal carcinoma), and HCT116DoxR (colorectal carcinoma resistant to doxorubicin) and normal primary fibroblasts revealed that Cu(II) complexes with 4-quinolinyl, 4-methoxy-1-naphthyl, 2-furanyl, and 2-pyridynyl substituents showed superior therapeutic potential in HCT116DoxR cells with significantly reduced cytotoxicity in normal fibroblasts (42-129× lower). Besides their cytotoxicity, the Cu(II) complexes are able to increase intracellular ROS and interfere with cell cycle progression, leading to cell death by apoptosis and autophagy. Importantly, they demonstrated antimetastatic and antiangiogenic properties without in vivo toxicity. In accordance with their nuclear accumulation, the Cu(II) complexes are able to cleave pDNA and interact with bovine serum albumin, which is a good indication of their ability for internalization and transport toward tumor cells.DCV - Departamento de Ciências da VidaUCIBIO - Applied Molecular Biosciences UnitRUNChoroba, KatarzynaMachura, BarbaraErfurt, KarolCasimiro, Ana RitaCordeiro, SandraBaptista, Pedro V.Fernandes, Alexandra R.2024-05-23T00:22:44Z2024-04-112024-04-11T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article24application/pdfhttp://hdl.handle.net/10362/167688eng0022-2623PURE: 91715137https://doi.org/10.1021/acs.jmedchem.4c00119info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-09-09T01:38:41Zoai:run.unl.pt:10362/167688Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-09-09T01:38:41Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ-Bridged Crystal Structure Biological Activities from 2D and 3D Tumor Spheroids to In Vivo Models |
title |
Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ-Bridged Crystal Structure |
spellingShingle |
Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ-Bridged Crystal Structure Choroba, Katarzyna Molecular Medicine Drug Discovery SDG 3 - Good Health and Well-being |
title_short |
Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ-Bridged Crystal Structure |
title_full |
Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ-Bridged Crystal Structure |
title_fullStr |
Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ-Bridged Crystal Structure |
title_full_unstemmed |
Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ-Bridged Crystal Structure |
title_sort |
Copper(II) Complexes with 2,2′:6′,2″-Terpyridine Derivatives Displaying Dimeric Dichloro−μ-Bridged Crystal Structure |
author |
Choroba, Katarzyna |
author_facet |
Choroba, Katarzyna Machura, Barbara Erfurt, Karol Casimiro, Ana Rita Cordeiro, Sandra Baptista, Pedro V. Fernandes, Alexandra R. |
author_role |
author |
author2 |
Machura, Barbara Erfurt, Karol Casimiro, Ana Rita Cordeiro, Sandra Baptista, Pedro V. Fernandes, Alexandra R. |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
DCV - Departamento de Ciências da Vida UCIBIO - Applied Molecular Biosciences Unit RUN |
dc.contributor.author.fl_str_mv |
Choroba, Katarzyna Machura, Barbara Erfurt, Karol Casimiro, Ana Rita Cordeiro, Sandra Baptista, Pedro V. Fernandes, Alexandra R. |
dc.subject.por.fl_str_mv |
Molecular Medicine Drug Discovery SDG 3 - Good Health and Well-being |
topic |
Molecular Medicine Drug Discovery SDG 3 - Good Health and Well-being |
description |
This work was cofinanced by national funds from FCT-Fundação para a Ciência e a Tecnologia, I.P., in the scope of the project UIDP/04378/2020 (doi: 10.54499/UIDP/04378/2020) and UIDB/04378/2020 (doi: 10.54499/UIDB/04378/2020) of the Research Unit on Applied Molecular Biosciences-UCIBIO and the project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy-i4HB and doctoral grant 2021.08629.BD (S.C.), and project NANOHEAT (doi: 10.54499/2022.04315.PTDC) and the Research Excellence Initiative of the University of Silesia in Katowice (B.M.). K.C. acknowledges funding from the National Science Center of Poland grant MINIATURA no. 2022/06/X/ST4/00351. Publisher Copyright: © 2024 The Authors. Published by American Chemical Society. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-05-23T00:22:44Z 2024-04-11 2024-04-11T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/167688 |
url |
http://hdl.handle.net/10362/167688 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
0022-2623 PURE: 91715137 https://doi.org/10.1021/acs.jmedchem.4c00119 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
24 application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817546016898940928 |